Outlook Therapeutics, Inc.
OTLK
Jodie situation report
Outlook Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.
- OTLK's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if OTLK's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind OTLK
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CORCencora, Inc.partnerDec 19, 2025 ▾
“We have entered into a strategic collaboration agreement with Cencora to support the commercial launch of ONS-5010/LYTENAVA globally.”
AMGNAmgen Inc.competitorDec 19, 2025 ▾
“Key competitors include Novartis (Lucentis ® , Beovu ® ), Regeneron (Eylea ® ), Genentech (Vabysmo ® ), Biogen and Coherus (Lucentis ® biosimilars), and Amgen (Eylea ® biosimilar).”
Depended on by
OCGNOcugen, Inc.competitorMar 4, 2026 ▾
“Companies that may compete with our OCU200 product candidate include Roche AG, Regeneron Pharmaceuticals, Inc., AsclepiX Therapeutics, Inc., Outlook Therapeutics, Inc., Novartis AG, Oxurion NV, Unity Biotechnology, Inc., Opthea Limited, and 4D Molecular Thera…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
OTLK is currently a Follower in the organic co-movement group Electric Vehicle Components. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for OTLK; it is not active in the latest market snapshot.